Kunal Nepali

250 Wuxing Street
Taipei, TNQ 11031, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 80 publications

Dual SYK-HDAC Inhibitor Elicits Striking Efficacy against Acute Myeloid Leukemia: Rational Design, Synthesis, and Biological Evaluation.

Dual SYK-HDAC Inhibitor Elicits Striking Efficacy against Acute Myeloid Leukemia: Rational Design, Synthesis, and Biological Evaluation.

Journal: Journal of medicinal chemistry

Published: June 09, 2026

Palladium-catalysed synthesis of small-molecule epigenetic inhibitors as anticancer therapeutics.

Palladium-catalysed synthesis of small-molecule epigenetic inhibitors as anticancer therapeutics.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: February 16, 2026

Recent advances in small molecule ATR kinase inhibitors as anticancer agents.

Recent advances in small molecule ATR kinase inhibitors as anticancer agents.

Journal: Future medicinal chemistry

Published: January 28, 2026

The HDAC Inhibitor RM-3-22 Suppresses Triple-Negative Breast Cancer by Uncoupling Autophagy to Drive FSP1-Dependent Ferroptosis.

The HDAC Inhibitor RM-3-22 Suppresses Triple-Negative Breast Cancer by Uncoupling Autophagy to Drive FSP1-Dependent Ferroptosis.

Journal: Translational research : the journal of laboratory and clinical medicine

Published: January 24, 2026

A novel dual CDC25-HDAC inhibitor suppresses glioblastoma progression via chromosomal passenger complex disruption.

A novel dual CDC25-HDAC inhibitor suppresses glioblastoma progression via chromosomal passenger complex disruption.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 08, 2025

Multi-Targeting Ligands as Prospective Therapeutics for Alzheimer's Disease, a Prevalent Neurodegenerative Disorder: Mechanistic Insights, Emerging Targets and Drug Discovery Campaigns.

Multi-Targeting Ligands as Prospective Therapeutics for Alzheimer's Disease, a Prevalent Neurodegenerative Disorder: Mechanistic Insights, Emerging Targets and Drug Discovery Campaigns.

Journal: Medicinal research reviews

Published: September 06, 2025

Medicinal chemistry breakthroughs on ATM, ATR, and DNA-PK inhibitors as prospective cancer therapeutics.

Medicinal chemistry breakthroughs on ATM, ATR, and DNA-PK inhibitors as prospective cancer therapeutics.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: April 21, 2025

Olaparib-Cediranib Hybrid as Dual PARP-VEGFR3 Inhibitor Elicits Antitumor Efficacy: Rational Design, Synthesis, Biological Evaluation and Construction of a Charge Convertible pH Responsive Nanoformulation.

Olaparib-Cediranib Hybrid as Dual PARP-VEGFR3 Inhibitor Elicits Antitumor Efficacy: Rational Design, Synthesis, Biological Evaluation and Construction of a Charge Convertible pH Responsive Nanoformulation.

Journal: Bioorganic chemistry

Published: April 15, 2025

Anticancer activity of RM-3-22: a TAZQ-based hydroxamic acid derivative targeting NSCLC in vitro and in vivo.

Anticancer activity of RM-3-22: a TAZQ-based hydroxamic acid derivative targeting NSCLC in vitro and in vivo.

Journal: Frontiers in pharmacology

Published: December 13, 2024

Advancing glioblastoma therapy: Learning from the past and innovations for the future.

Advancing glioblastoma therapy: Learning from the past and innovations for the future.

Journal: Cancer letters

Published: November 14, 2024

Scaffold hopping approaches for dual-target antitumor drug discovery: opportunities and challenges.

Scaffold hopping approaches for dual-target antitumor drug discovery: opportunities and challenges.

Journal: Expert opinion on drug discovery

Published: October 18, 2024

Syntheses of LSD1/HDAC Inhibitors with Demonstrated Efficacy against Colorectal Cancer: In Vitro and In Vivo Studies Including Patient-Derived Organoids.

Syntheses of LSD1/HDAC Inhibitors with Demonstrated Efficacy against Colorectal Cancer: In Vitro and In Vivo Studies Including Patient-Derived Organoids.

Journal: Journal of medicinal chemistry

Published: September 25, 2024

Showing 1-12 of 80

Last Updated: 09/26/2026